vs
MADRIGAL PHARMACEUTICALS, INC.（MDGL）与MACOM Technology Solutions Holdings, Inc.（MTSI）财务数据对比。点击上方公司名可切换其他公司
MADRIGAL PHARMACEUTICALS, INC.的季度营收约是MACOM Technology Solutions Holdings, Inc.的1.1倍（$321.1M vs $289.0M），MACOM Technology Solutions Holdings, Inc.净利率更高（16.0% vs -18.2%，领先34.3%），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs 22.5%）
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
MACOM是美国知名的射频、微波及毫米波半导体器件与组件研发生产商，总部位于马萨诸塞州洛厄尔，2005年曾是当地规模最大的私营雇主。公司已通过ISO9001国际质量体系认证及ISO14001环境管理体系认证，在北美、欧洲、亚洲及澳大利亚均设有设计中心与销售办事处。
MDGL vs MTSI — 直观对比
营收规模更大
MDGL
是对方的1.1倍
$289.0M
营收增速更快
MDGL
高出188.3%
22.5%
净利率更高
MTSI
高出34.3%
-18.2%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $321.1M | $289.0M |
| 净利润 | $-58.6M | $46.3M |
| 毛利率 | — | 56.9% |
| 营业利润率 | -18.6% | 17.6% |
| 净利率 | -18.2% | 16.0% |
| 营收同比 | 210.8% | 22.5% |
| 净利润同比 | 1.4% | 46.3% |
| 每股收益（稀释后） | $-2.55 | $0.60 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDGLMTSI
| Q2 26 | — | $289.0M | ||
| Q1 26 | — | $271.6M | ||
| Q4 25 | $321.1M | $261.2M | ||
| Q3 25 | $287.3M | $252.1M | ||
| Q2 25 | $212.8M | $235.9M | ||
| Q1 25 | $137.3M | $218.1M | ||
| Q4 24 | $103.3M | — | ||
| Q3 24 | $62.2M | $200.7M |
净利润MDGLMTSI
| Q2 26 | — | $46.3M | ||
| Q1 26 | — | $48.8M | ||
| Q4 25 | $-58.6M | $45.1M | ||
| Q3 25 | $-114.2M | $36.5M | ||
| Q2 25 | $-42.3M | $31.7M | ||
| Q1 25 | $-73.2M | $-167.5M | ||
| Q4 24 | $-59.4M | — | ||
| Q3 24 | $-107.0M | $29.4M |
毛利率MDGLMTSI
| Q2 26 | — | 56.9% | ||
| Q1 26 | — | 55.9% | ||
| Q4 25 | — | 54.5% | ||
| Q3 25 | — | 55.3% | ||
| Q2 25 | — | 55.2% | ||
| Q1 25 | 96.7% | 53.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.7% |
营业利润率MDGLMTSI
| Q2 26 | — | 17.6% | ||
| Q1 26 | — | 15.9% | ||
| Q4 25 | -18.6% | 15.2% | ||
| Q3 25 | -39.7% | 14.9% | ||
| Q2 25 | -22.2% | 14.8% | ||
| Q1 25 | -57.8% | 8.0% | ||
| Q4 24 | -64.8% | — | ||
| Q3 24 | -187.1% | 13.7% |
净利率MDGLMTSI
| Q2 26 | — | 16.0% | ||
| Q1 26 | — | 18.0% | ||
| Q4 25 | -18.2% | 17.3% | ||
| Q3 25 | -39.8% | 14.5% | ||
| Q2 25 | -19.9% | 13.4% | ||
| Q1 25 | -53.4% | -76.8% | ||
| Q4 24 | -57.5% | — | ||
| Q3 24 | -172.0% | 14.7% |
每股收益（稀释后）MDGLMTSI
| Q2 26 | — | $0.60 | ||
| Q1 26 | — | $0.64 | ||
| Q4 25 | $-2.55 | $0.67 | ||
| Q3 25 | $-5.08 | $0.48 | ||
| Q2 25 | $-1.90 | $0.42 | ||
| Q1 25 | $-3.32 | $-2.30 | ||
| Q4 24 | $-2.50 | — | ||
| Q3 24 | $-4.92 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $198.7M | $664.9M |
| 总债务越低越好 | $339.9M | $0 |
| 股东权益账面价值 | $602.7M | — |
| 总资产 | $1.3B | $2.0B |
| 负债/权益比越低杠杆越低 | 0.56× | — |
8季度趋势，按日历期对齐
现金及短期投资MDGLMTSI
| Q2 26 | — | $664.9M | ||
| Q1 26 | — | $768.5M | ||
| Q4 25 | $198.7M | $786.0M | ||
| Q3 25 | $295.7M | $735.2M | ||
| Q2 25 | $186.2M | $681.5M | ||
| Q1 25 | $183.6M | $656.5M | ||
| Q4 24 | $100.0M | — | ||
| Q3 24 | $232.7M | $581.9M |
总债务MDGLMTSI
| Q2 26 | — | $0 | ||
| Q1 26 | — | — | ||
| Q4 25 | $339.9M | — | ||
| Q3 25 | $339.8M | — | ||
| Q2 25 | $118.4M | — | ||
| Q1 25 | $118.0M | — | ||
| Q4 24 | $117.6M | — | ||
| Q3 24 | $117.1M | — |
股东权益MDGLMTSI
| Q2 26 | — | — | ||
| Q1 26 | — | $1.4B | ||
| Q4 25 | $602.7M | $1.3B | ||
| Q3 25 | $625.7M | $1.3B | ||
| Q2 25 | $696.0M | $1.2B | ||
| Q1 25 | $710.6M | $1.2B | ||
| Q4 24 | $754.4M | — | ||
| Q3 24 | $777.2M | $1.1B |
总资产MDGLMTSI
| Q2 26 | — | $2.0B | ||
| Q1 26 | — | $2.1B | ||
| Q4 25 | $1.3B | $2.1B | ||
| Q3 25 | $1.4B | $2.0B | ||
| Q2 25 | $1.0B | $1.9B | ||
| Q1 25 | $996.6M | $1.8B | ||
| Q4 24 | $1.0B | — | ||
| Q3 24 | $1.1B | $1.8B |
负债/权益比MDGLMTSI
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 0.56× | — | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | 0.17× | — | ||
| Q4 24 | 0.16× | — | ||
| Q3 24 | 0.15× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-133.5M | $121.6M |
| 自由现金流经营现金流 - 资本支出 | $-133.8M | — |
| 自由现金流率自由现金流/营收 | -41.7% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | 2.62× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MDGLMTSI
| Q2 26 | — | $121.6M | ||
| Q1 26 | — | $42.9M | ||
| Q4 25 | $-133.5M | $69.6M | ||
| Q3 25 | $79.8M | $60.4M | ||
| Q2 25 | $-47.1M | $38.7M | ||
| Q1 25 | $-88.9M | $66.7M | ||
| Q4 24 | $-104.5M | — | ||
| Q3 24 | $-67.0M | $62.3M |
自由现金流MDGLMTSI
| Q2 26 | — | — | ||
| Q1 26 | — | $30.0M | ||
| Q4 25 | $-133.8M | $49.4M | ||
| Q3 25 | $79.0M | $51.6M | ||
| Q2 25 | — | $30.5M | ||
| Q1 25 | — | $61.3M | ||
| Q4 24 | $-104.7M | — | ||
| Q3 24 | $-67.8M | $57.1M |
自由现金流率MDGLMTSI
| Q2 26 | — | — | ||
| Q1 26 | — | 11.0% | ||
| Q4 25 | -41.7% | 18.9% | ||
| Q3 25 | 27.5% | 20.5% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 28.1% | ||
| Q4 24 | -101.3% | — | ||
| Q3 24 | -109.0% | 28.5% |
资本支出强度MDGLMTSI
| Q2 26 | — | — | ||
| Q1 26 | — | 4.8% | ||
| Q4 25 | 0.1% | 7.7% | ||
| Q3 25 | 0.3% | 3.5% | ||
| Q2 25 | 0.0% | 3.5% | ||
| Q1 25 | 0.0% | 2.4% | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 1.3% | 2.6% |
现金转化率MDGLMTSI
| Q2 26 | — | 2.62× | ||
| Q1 26 | — | 0.88× | ||
| Q4 25 | — | 1.54× | ||
| Q3 25 | — | 1.65× | ||
| Q2 25 | — | 1.22× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
MTSI
暂无分部数据
